A patient is about to begin treatment with isoniazid. The nurse learns that the patient also takes phenytoin (Dilantin) for seizures. The nurse will contact the provider to discuss:
a. reducing the isoniazid dose.
b. reducing the phenytoin dose.
c. monitoring isoniazid levels.
d. monitoring phenytoin levels.
ANS: D
Isoniazid is a strong inhibitor of three cytochrome P450 enzymes, and inhibition of these enzymes can raise the levels of other drugs, including phenytoin. Patients taking phenytoin should have the levels of this drug monitored, and the dose should be reduced if appropriate. Reducing the dose of isoniazid is not indicated. It is not necessary to monitor isoniazid levels.
You might also like to view...
A parent asks about the process of bone growth. When explaining bone development to the parent, which substances does the nurse include in the teaching session as being necessary? (Select all that apply.)
A. Calcitonin B. Calcium C. Estrogen D. Thyroid hormones E. Vitamin D
Depression in the elderly is
1. rare. 2. common. 3. nonexistent. 4. seen occasionally.
Which is helpful to tell a mother who is concerned about preventing sleep problems in her preschool child?
a. Have the child always sleep in a quiet, dar-kened room. b. Provide high-carbohydrate snacks before bedtime. c. Communicate with the child's daytime caretaker to encourage a longer nap. d. Use a nightlight in the child's room.
How does acarbose (Precose) prevent blood glucose levels from rising too high?
a. It limits the intestinal enzyme that converts complex carbohydrates into glucose. b. It blocks the absorption of carbohydrates and glucose in the intestines. c. It enhances the binding of insulin to its membrane receptors. d. It releases more insulin from pancreatic beta cells.